Livzon Pharmaceutical Group Inc. Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc.

000513

Rang in Aktien #4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
Aktienkurs
$3.90
Marktkapitalisierung
$3.17B
Veränderung (1 Tag)
-3.49%
Veränderung (1 Jahr)
-25.88%
Land
CN
Handel Livzon Pharmaceutical Group Inc. (000513)

Kategorie

Healthcare
Dividendenhistorie für Livzon Pharmaceutical Group Inc. (000513)
Livzon Pharmaceutical Group Inc. (Aktienkürzel: 000513) zahlte insgesamt 27 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: $13.88
Dividendenrendite (TTM): 0.0942
Dividendenzahlungen für Livzon Pharmaceutical Group Inc. (000513) von 1995 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
2026 (TTM) $1.02 -7.27%
2025 $1.10 -18.52%
2024 $1.35 -15.63%
2023 $1.60 23.08%
2022 $1.30 4.00%
2021 $1.25 8.69%
2020 $1.15 24.59%
2019 $0.9231 -22.00%
2018 $1.18 419.95%
2017 $0.2276 0.00%
2016 $0.2276 550.29%
2015 $0.035 -80.01%
2014 $0.1751 0.00%
2013 $0.1751 0.00%
2012 $0.1751 400.29%
2011 $0.035 -33.33%
2010 $0.0525 50.00%
2009 $0.035 -80.01%
2008 $0.1751 267.09%
2005 $0.0477 50.00%
2004 $0.0318 0.00%
2003 $0.0318 234.74%
2002 $0.0095 -40.25%
1999 $0.0159 -68.95%
1996 $0.0512 -33.33%
1995 $0.0768 0.00%
Liste aller Dividendenzahlungen
Jahr Dividende ändert
2026 (TTM) $1.02 -7.27%
2025 $1.10 -18.52%
2024 $1.35 -15.63%
2023 $1.60 23.08%
2022 $1.30 4.00%
2021 $1.25 8.69%
2020 $1.15 24.59%
2019 $0.9231 -53.85%
2018 $2.00 300.00%
2017 $0.5 0.00%
2016 $0.5 400.00%
2015 $0.1 -80.00%
2014 $0.5 0.00%
2013 $0.5 0.00%
2012 $0.5 400.00%
2011 $0.1 -33.33%
2010 $0.15 50.00%
2009 $0.1 -80.00%
2008 $0.5 233.33%
2005 $0.15 50.00%
2004 $0.1 0.00%
2003 $0.1 233.33%
2002 $0.03 -40.00%
1999 $0.05 -75.00%
1996 $0.2 -33.33%
1995 $0.3 0.00%
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber